Viatris to acquire Pacira BioSciences for $36.50 per share in cashOct 8M&APacira Pharmaceuticals, IncViatris Inc.
Pacira reports Q2 2026 results, updates guidance after iovera° sale to Zimmer BiometAug 4Quarterly updateenekinragene inzadenovecPacira Pharmaceuticals, Inc